Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of Erythrocytes01:27

Disorders of Erythrocytes

2.7K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.7K
Hematopoiesis01:21

Hematopoiesis

9.7K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
9.7K
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

11.2K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
11.2K
Disorders of Hemostasis01:24

Disorders of Hemostasis

2.7K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.7K
Disorders of Leukocytes01:27

Disorders of Leukocytes

2.4K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
2.4K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

2.3K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microtubules and Alp7-Alp14 (TACC-TOG) reposition chromosomes before meiotic segregation.

Nature cell biology·2013
Same author

Exacerbated airway toxicity of environmental oxidant ozone in mice deficient in Nrf2.

Oxidative medicine and cellular longevity·2013
Same author

Proper microtubule structure is vital for timely progression through meiosis in fission yeast.

PloS one·2013
Same author

Transforming growth factor-β induces transcription factors MafK and Bach1 to suppress expression of the heme oxygenase-1 gene.

The Journal of biological chemistry·2013
Same author

A mouse model of adult-onset anaemia due to erythropoietin deficiency.

Nature communications·2013
Same author

Critical role of Nrf2 in oxidative stress-induced retinal ganglion cell death.

Journal of neurochemistry·2013

Related Experiment Video

Updated: Mar 20, 2026

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
08:00

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

14.6K

GATA-related hematologic disorders.

Ritsuko Shimizu1, Masayuki Yamamoto2

  • 1Department of Molecular Hematology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Experimental Hematology
|May 29, 2016
PubMed
Summary

The balance of GATA1 and GATA2 transcription factors is crucial for blood cell development and function. Disruptions in these factors are linked to hematologic diseases and leukemia.

More Related Videos

Application of Aorta-gonad-mesonephros Explant Culture System in Developmental Hematopoiesis
07:38

Application of Aorta-gonad-mesonephros Explant Culture System in Developmental Hematopoiesis

Published on: November 3, 2017

9.0K
Direct Induction of Hemogenic Endothelium and Blood by Overexpression of Transcription Factors in Human Pluripotent Stem Cells
08:14

Direct Induction of Hemogenic Endothelium and Blood by Overexpression of Transcription Factors in Human Pluripotent Stem Cells

Published on: December 3, 2015

8.0K

Related Experiment Videos

Last Updated: Mar 20, 2026

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
08:00

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

14.6K
Application of Aorta-gonad-mesonephros Explant Culture System in Developmental Hematopoiesis
07:38

Application of Aorta-gonad-mesonephros Explant Culture System in Developmental Hematopoiesis

Published on: November 3, 2017

9.0K
Direct Induction of Hemogenic Endothelium and Blood by Overexpression of Transcription Factors in Human Pluripotent Stem Cells
08:14

Direct Induction of Hemogenic Endothelium and Blood by Overexpression of Transcription Factors in Human Pluripotent Stem Cells

Published on: December 3, 2015

8.0K

Area of Science:

  • Hematology
  • Molecular Biology
  • Genetics

Background:

  • GATA1 and GATA2 are key transcription factors regulating blood cell formation.
  • They have overlapping but distinct roles and expression patterns during hematopoiesis.
  • The dynamic interplay between GATA2 and GATA1 is essential for erythroid differentiation.

Purpose of the Study:

  • To explore the roles of GATA1 and GATA2 in hematopoiesis.
  • To investigate the connection between GATA factor dysregulation and hematologic disorders.
  • To focus on the gene expression regulation of GATA factors in disease.

Main Methods:

  • Loss-of-function analyses in mouse models.
  • Transgenic expression studies.
  • Analysis of naturally occurring leukemias in GATA1-knockdown mice.

Main Results:

  • GATA1 and GATA2 are functionally nonredundant in hematopoiesis.
  • Dynamic expression switching from GATA2 to GATA1 is vital for erythroid differentiation.
  • Transgenic GATA2 expression can rescue GATA1 deficiency, highlighting the importance of expression timing.
  • Leukemic stem cells show altered functions upon chemotherapy exposure, potentially explaining relapsed leukemia features.

Conclusions:

  • The precise regulation and dynamic expression of GATA1 and GATA2 are critical for maintaining hematopoietic homeostasis.
  • Imbalances in GATA factor expression are associated with specific hematologic diseases.
  • Understanding GATA factor regulation is key to addressing GATA1- and GATA2-related blood disorders.